2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole

C432H273N45O12 — CID 157454110

IUPAC2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole
SMILESCC(C)(C)c1ccc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccccc5)o4)cc3)c3ccccc23)cn1.Cc1ccc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccccc5)o4)cc3)c3ccccc23)cn1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cc6ccccc6cn5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6cnncc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6ncncc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6nnccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5ccnc6ncccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnc6ccccc6n5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnc6ncccc6c5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnnc6ccccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5ncnc6ccccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5nncc6ccccc56)c5ccccc45)cc3)o2)cc1
InChIInChI=1S/C37H23N3O.C37H29N3O.9C36H22N4O.C34H23N3O/c1-2-10-25(11-3-1)36-39-40-37(41-36)26-20-18-24(19-21-26)34-29-14-6-8-16-31(29)35(32-17-9-7-15-30(32)34)33-22-27-12-4-5-13-28(27)23-38-33;1-37(2,3)32-22-21-27(23-38-32)34-30-15-9-7-13-28(30)33(29-14-8-10-16-31(29)34)24-17-19-26(20-18-24)36-40-39-35(41-36)25-11-5-4-6-12-25;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)33-27-13-4-6-15-29(27)34(30-16-7-5-14-28(30)33)31-22-37-38-32-17-9-8-12-26(31)32;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)32-26-12-4-6-14-28(26)33(29-15-7-5-13-27(29)32)34-30-16-8-9-17-31(30)37-22-38-34;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)33-26-12-4-6-14-28(26)34(29-15-7-5-13-27(29)33)32-22-37-30-16-8-9-17-31(30)38-32;1-2-9-24(10-3-1)35-39-40-36(41-35)25-18-16-23(17-19-25)32-28-12-4-6-14-30(28)33(31-15-7-5-13-29(31)32)27-21-26-11-8-20-37-34(26)38-22-27;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-27-12-4-6-14-29(27)34(30-15-7-5-13-28(30)33)31-16-8-11-26-21-37-38-22-32(26)31;1-2-9-24(10-3-1)35-39-40-36(41-35)25-18-16-23(17-19-25)32-26-11-4-6-13-28(26)33(29-14-7-5-12-27(29)32)30-20-22-38-34-31(30)15-8-21-37-34;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-26-11-4-6-13-28(26)34(29-14-7-5-12-27(29)33)30-15-8-16-32-31(30)21-37-22-38-32;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-28-11-4-6-13-30(28)34(31-14-7-5-12-29(31)33)27-15-8-16-32-26(27)21-22-37-38-32;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)32-28-14-6-8-16-30(28)33(31-17-9-7-15-29(31)32)34-27-13-5-4-12-26(27)22-37-38-34;1-22-15-16-26(21-35-22)32-29-13-7-5-11-27(29)31(28-12-6-8-14-30(28)32)23-17-19-25(20-18-23)34-37-36-33(38-34)24-9-3-2-4-10-24/h1-23H;4-23H,1-3H3;9*1-22H;2-21H,1H3
InChIKeyBTDMBXUMORVMNA-UHFFFAOYSA-N
MW6286.24 g/mol
LogP108.96
Rot. Bonds48

About 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole

2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole (PubChem CID 157454110) has the molecular formula C432H273N45O12 and a molecular weight of 6286.24 g/mol. Its IUPAC name is 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole.

Molecular Properties

Compound Name2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole
PubChem CID157454110
Molecular FormulaC432H273N45O12
Molecular Weight6286.24 g/mol
Exact Mass6281.21
IUPAC Name2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole
SMILESCC(C)(C)c1ccc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccccc5)o4)cc3)c3ccccc23)cn1.Cc1ccc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccccc5)o4)cc3)c3ccccc23)cn1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cc6ccccc6cn5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6cnncc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6ncncc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6nnccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5ccnc6ncccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnc6ccccc6n5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnc6ncccc6c5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnnc6ccccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5ncnc6ccccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5nncc6ccccc56)c5ccccc45)cc3)o2)cc1
InChIInChI=1S/C37H23N3O.C37H29N3O.9C36H22N4O.C34H23N3O/c1-2-10-25(11-3-1)36-39-40-37(41-36)26-20-18-24(19-21-26)34-29-14-6-8-16-31(29)35(32-17-9-7-15-30(32)34)33-22-27-12-4-5-13-28(27)23-38-33;1-37(2,3)32-22-21-27(23-38-32)34-30-15-9-7-13-28(30)33(29-14-8-10-16-31(29)34)24-17-19-26(20-18-24)36-40-39-35(41-36)25-11-5-4-6-12-25;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)33-27-13-4-6-15-29(27)34(30-16-7-5-14-28(30)33)31-22-37-38-32-17-9-8-12-26(31)32;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)32-26-12-4-6-14-28(26)33(29-15-7-5-13-27(29)32)34-30-16-8-9-17-31(30)37-22-38-34;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)33-26-12-4-6-14-28(26)34(29-15-7-5-13-27(29)33)32-22-37-30-16-8-9-17-31(30)38-32;1-2-9-24(10-3-1)35-39-40-36(41-35)25-18-16-23(17-19-25)32-28-12-4-6-14-30(28)33(31-15-7-5-13-29(31)32)27-21-26-11-8-20-37-34(26)38-22-27;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-27-12-4-6-14-29(27)34(30-15-7-5-13-28(30)33)31-16-8-11-26-21-37-38-22-32(26)31;1-2-9-24(10-3-1)35-39-40-36(41-35)25-18-16-23(17-19-25)32-26-11-4-6-13-28(26)33(29-14-7-5-12-27(29)32)30-20-22-38-34-31(30)15-8-21-37-34;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-26-11-4-6-13-28(26)34(29-14-7-5-12-27(29)33)30-15-8-16-32-31(30)21-37-22-38-32;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-28-11-4-6-13-30(28)34(31-14-7-5-12-29(31)33)27-15-8-16-32-26(27)21-22-37-38-32;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)32-28-14-6-8-16-30(28)33(31-17-9-7-15-29(31)32)34-27-13-5-4-12-26(27)22-37-38-34;1-22-15-16-26(21-35-22)32-29-13-7-5-11-27(29)31(28-12-6-8-14-30(28)32)23-17-19-25(20-18-23)34-37-36-33(38-34)24-9-3-2-4-10-24/h1-23H;4-23H,1-3H3;9*1-22H;2-21H,1H3
InChIKeyBTDMBXUMORVMNA-UHFFFAOYSA-N
XLogP108.96
TPSA737.73 Ų
H-Bond Donors
H-Bond Acceptors57
Rotatable Bonds48
Heavy Atoms489
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5006286.24
LogP ≤ 5108.96
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1057

Analyze 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157163912
methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]purin-8-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157371199
16-(4-Imidazo[1,2-a]pyrimidin-2-ylphenyl)-9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-[3-methyl-5-(trifluoromethyl)phenyl]-16-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;2-phenyl-5-(9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaen-16-yl)-1,3,4-oxadiazole
CID 158772688
2-[3,5-Bis(5-naphthalen-1-yl-1,3,4-oxadiazol-2-yl)phenyl]-5-naphthalen-1-yl-1,3,4-oxadiazole;3-(4-tert-butylphenyl)-4-(4-ethylphenyl)-5-(4-phenylphenyl)-1,2,4-triazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;3-(4-tert-butylphenyl)-4-phenyl-5-(4-phenylphenyl)-1,2,4-triazole;2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline;4,7-diphenyl-1,10-phenanthroline;2-[4-[1,1,1,3,3,3-hexafluoro-2-[4-[5-(4-phenylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]propan-2-yl]phenyl]-5-(4-phenylphenyl)-1,3,4-oxadiazole;4-naphthalen-1-yl-3,5-diphenyl-1,2,4-triazole;9-[4-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]carbazole
CID 160130312
2,7-Bis(4-hexylphenyl)-4,9-diphenylpyrido[2,3-g]quinoline;2-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole;2-[3,5-bis[3-phenyl-6-(trifluoromethyl)quinoxalin-2-yl]phenyl]-6-methyl-3-phenylquinoxaline;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;2-(3-methylphenyl)-5-[4-[tris[4-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]phenyl]-1,3,4-oxadiazole
CID 160311315
1-[4,6-Bis(2-methylbenzimidazol-1-yl)-1,3,5-triazin-2-yl]-2-methylbenzimidazole;9-butan-2-ylcarbazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;2-(2,4-difluorobenzene-6-id-1-yl)pyridine;bis(iridium);2-phenylpyridine;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
CID 161135612
CID 161363274
CID 161363274
7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;4-[[6-oxo-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl]benzonitrile;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 167617890
5-(4-Tert-butylphenyl)-3-[2-[3-[1-[3-(4,7-diphenyl-1,10-phenanthrolin-1-ium-1-yl)phenyl]benzimidazol-2-yl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-3-phenylbenzimidazol-5-yl]-2-(4-phenylphenyl)-1,3,4-oxadiazol-3-ium
CID 91238558
2-Methyl-5-[5,5,21,21-tetramethyl-19-(5-methyl-1,3,4-oxadiazol-2-yl)-12-[5,5,21,21-tetramethyl-3,19-di(pyrimidin-2-yl)-1,17-diazanonacyclo[20.10.1.16,10.02,20.04,18.011,16.026,33.027,32.017,34]tetratriaconta-2(20),3,6,8,10(34),11,13,15,18,22,24,26(33),27,29,31-pentadecaen-12-yl]-1,17-diazanonacyclo[20.10.1.16,10.02,20.04,18.011,16.026,33.027,32.017,34]tetratriaconta-2(20),3,6,8,10(34),11,13,15,18,22,24,26(33),27,29,31-pentadecaen-3-yl]-1,3,4-oxadiazole
CID 146431270
2-(4-Tert-butylphenyl)-5-[7'-(3-phenyl-4-pyridin-2-ylimidazo[4,5-c]quinolin-2-yl)-9,9'-spirobi[fluorene]-2'-yl]-1,3,4-oxadiazole
CID 146581064
2-(4-Tert-butylphenyl)-5-[9,9-diphenyl-7-(3-phenyl-4-pyridin-2-ylimidazo[4,5-c]quinolin-2-yl)fluoren-2-yl]-1,3,4-oxadiazole
CID 146581066

Frequently Asked Questions

What is the IUPAC name of 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole?
The IUPAC name of 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole (CID 157454110) is 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole.
What is the SMILES notation for 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole?
The canonical SMILES for 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole is CC(C)(C)c1ccc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccccc5)o4)cc3)c3ccccc23)cn1.Cc1ccc(-c2c3ccccc3c(-c3ccc(-c4nnc(-c5ccccc5)o4)cc3)c3ccccc23)cn1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cc6ccccc6cn5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6cnncc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6ncncc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cccc6nnccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5ccnc6ncccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnc6ccccc6n5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnc6ncccc6c5)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5cnnc6ccccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5ncnc6ccccc56)c5ccccc45)cc3)o2)cc1.c1ccc(-c2nnc(-c3ccc(-c4c5ccccc5c(-c5nncc6ccccc56)c5ccccc45)cc3)o2)cc1.
What is the InChIKey of 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole?
The InChIKey is BTDMBXUMORVMNA-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H23N3O.C37H29N3O.9C36H22N4O.C34H23N3O/c1-2-10-25(11-3-1)36-39-40-37(41-36)26-20-18-24(19-21-26)34-29-14-6-8-16-31(29)35(32-17-9-7-15-30(32)34)33-22-27-12-4-5-13-28(27)23-38-33;1-37(2,3)32-22-21-27(23-38-32)34-30-15-9-7-13-28(30)33(29-14-8-10-16-31(29)34)24-17-19-26(20-18-24)36-40-39-35(41-36)25-11-5-4-6-12-25;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)33-27-13-4-6-15-29(27)34(30-16-7-5-14-28(30)33)31-22-37-38-32-17-9-8-12-26(31)32;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)32-26-12-4-6-14-28(26)33(29-15-7-5-13-27(29)32)34-30-16-8-9-17-31(30)37-22-38-34;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)33-26-12-4-6-14-28(26)34(29-15-7-5-13-27(29)33)32-22-37-30-16-8-9-17-31(30)38-32;1-2-9-24(10-3-1)35-39-40-36(41-35)25-18-16-23(17-19-25)32-28-12-4-6-14-30(28)33(31-15-7-5-13-29(31)32)27-21-26-11-8-20-37-34(26)38-22-27;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-27-12-4-6-14-29(27)34(30-15-7-5-13-28(30)33)31-16-8-11-26-21-37-38-22-32(26)31;1-2-9-24(10-3-1)35-39-40-36(41-35)25-18-16-23(17-19-25)32-26-11-4-6-13-28(26)33(29-14-7-5-12-27(29)32)30-20-22-38-34-31(30)15-8-21-37-34;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-26-11-4-6-13-28(26)34(29-14-7-5-12-27(29)33)30-15-8-16-32-31(30)21-37-22-38-32;1-2-9-24(10-3-1)35-39-40-36(41-35)25-19-17-23(18-20-25)33-28-11-4-6-13-30(28)34(31-14-7-5-12-29(31)33)27-15-8-16-32-26(27)21-22-37-38-32;1-2-10-24(11-3-1)35-39-40-36(41-35)25-20-18-23(19-21-25)32-28-14-6-8-16-30(28)33(31-17-9-7-15-29(31)32)34-27-13-5-4-12-26(27)22-37-38-34;1-22-15-16-26(21-35-22)32-29-13-7-5-11-27(29)31(28-12-6-8-14-30(28)32)23-17-19-25(20-18-23)34-37-36-33(38-34)24-9-3-2-4-10-24/h1-23H;4-23H,1-3H3;9*1-22H;2-21H,1H3.
What are the key properties of 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole?
2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole has a molecular weight of 6286.24 g/mol, XLogP of 108.96, 48 rotatable bonds, 0 hydrogen bond donors, and 57 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[10-(6-tert-butyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-4-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-cinnolin-5-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-(10-isoquinolin-3-ylanthracen-9-yl)phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(6-methyl-3-pyridinyl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-3-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-[4-[10-(1,8-naphthyridin-4-yl)anthracen-9-yl]phenyl]-5-phenyl-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-1-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-phthalazin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-4-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinazolin-5-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole;2-phenyl-5-[4-(10-quinoxalin-2-ylanthracen-9-yl)phenyl]-1,3,4-oxadiazole is sourced from PubChem (CID 157454110), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).